ARCHIVE

• 989 Bio-derived Products Recommended for Designation
  March 31, 2003

• OTC NEWS IN BRIEF
  March 31, 2003

• Trend Toward For-profit Participation in Healthcare "Will Not Stop": Mr Konoike
  March 31, 2003

• NEW PRODUCTS
  March 31, 2003

• Korosho Orders Kyorin to Issue Dear-Dr Letter on Gatifloxacin
  March 31, 2003

• Vision for Medical Devices Industry Announced
  March 31, 2003

• REGULATORY NEWS IN BRIEF
  March 31, 2003

• Notification on Safety Measures for Infusion Pumps Issued
  March 31, 2003

• Cost Should Be Calculated for Each Diagnosis Group: JHA Seminar
  March 31, 2003

• MEDICAL DEVICES NEWS IN BRIEF
  March 31, 2003

• If GE Use Will Rise Under DPC-based Flat-sum System?: Seminar
  March 31, 2003

• DIAGNOSTIC NEWS IN BRIEF
  March 31, 2003

• MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
  March 31, 2003

• WORLD NEWS IN BRIEF
  March 31, 2003

• JPMA President to Propose "Hybrid" NHI Price System
  March 31, 2003

• Yamanouchi Discovers 3 New Target Genes for Antidiabetics
  March 31, 2003

• JPMA Approves Plans to Strengthen Activities of Its Thinktank
  March 31, 2003

• March 31, 2003

• Tanabe Licenses Transmucosal Oral Fentanyl from Cephalon
  March 31, 2003

• Predicting Disease Prevalence to Be Major Issue: JPMA Seminar
  March 31, 2003

ページ

• « 先頭
• ‹ Prev
• …
• 608
• 609
• 610
• 611
• 612
• 613
• 614
• 615
• 616
• …
• Next ›
• 最終 »